Viewing Study NCT00510159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-27 @ 1:08 AM
Study NCT ID: NCT00510159
Status: COMPLETED
Last Update Posted: 2008-01-18
First Post: 2007-07-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Sponsor: Dafra Pharma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schistosoma Haematobium View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schistosoma haematobium View
None Praziquantel View
None Artesunate + Sulfamethoxypyrazine/pyrimethamine View
None Randomized double blind placebo controlled clinical trial View